Home
 Search
 Category
 Compounds
 Status
 Download
 Contacts
 Resources


Compound category: Organic compounds
(total 903 related compounds in database, current show from 801 to 810)
 
Compound name 2D structure Target pathogen(s) Related VF/VFcategory Max phase Reference(s)
N-[3-(2-aminopyrimidin-5-yl)phenyl]-3,5-dibromobenzamide Depiction based on curated SMILES N Br Br NH 2 O N H N Staphylococcus Biofilm Preclinical (in vitro) Weig AW, et al. 2021. RSC Med Chem
N-[3-(2-aminopyrimidin-5-yl)propyl]decanamide Depiction based on curated SMILES NH N H 2 N N CH 3 O Staphylococcus Biofilm Preclinical (in vitro) Lindsey EA, et al. 2012. Org Biomol Chem
N-[4-(2-aminopyrimidin-4-yl)phenyl]-3,5-dichlorobenzamide Depiction based on curated SMILES O N Cl Cl NH 2 N H N Staphylococcus Biofilm Preclinical (in vitro) Weig AW, et al. 2021. RSC Med Chem
[(2R)-6-azaniumyl-1-[3-[3-[[(2R)-2,6-bis(azaniumyl)hexanoyl]amino]propyl-hexadecanoylamino]propylamino]-1-oxohexan-2-yl]azanium Depiction based on curated SMILES + N H H H N H O H H + N H H H + N H H H CH 3 O N N H O H + N H H Staphylococcus Biofilm Preclinical (in vitro) Konai MM, et al. 2015. ACS Infect Dis
[(2R)-6-azaniumyl-1-[3-[3-[[(2R)-2,6-bis(azaniumyl)hexanoyl]amino]propyl-tetradecanoylamino]propylamino]-1-oxohexan-2-yl]azanium Depiction based on curated SMILES + N H H H HN O H + N H H H + N H H H O H 3 C N HN O H + N H H H Staphylococcus Biofilm Preclinical (in vitro) Konai MM, et al. 2015. ACS Infect Dis
[(2S)-6-azaniumyl-1-[3-[3-[[(2S)-2,6-bis(azaniumyl)hexanoyl]amino]propyl-decanoylamino]propylamino]-1-oxohexan-2-yl]azanium Depiction based on curated SMILES H + N H H H N H O + N H H H + N H H H O N CH 3 N H O H + N H H H Staphylococcus Biofilm Preclinical (in vitro) Konai MM, et al. 2015. ACS Infect Dis
[(2S)-6-azaniumyl-1-[3-[3-[[(2S)-2,6-bis(azaniumyl)hexanoyl]amino]propyl-dodecanoylamino]propylamino]-1-oxohexan-2-yl]azanium Depiction based on curated SMILES H + N H H H N H O + N H H H + N H H H O N CH 3 N H O H + N H H H Staphylococcus Biofilm Preclinical (in vitro) Konai MM, et al. 2015. ACS Infect Dis
[(2S)-6-azaniumyl-1-[3-[3-[[(2S)-2,6-bis(azaniumyl)hexanoyl]amino]propyl-hexadecanoylamino]propylamino]-1-oxohexan-2-yl]azanium Depiction based on curated SMILES + N H H H N H O H H + N H H H + N H H H CH 3 O N N H O H + N H H Staphylococcus Biofilm Preclinical (in vitro) Konai MM, et al. 2015. ACS Infect Dis
[(2S)-6-azaniumyl-1-[3-[3-[[(2S)-2,6-bis(azaniumyl)hexanoyl]amino]propyl-octadecanoylamino]propylamino]-1-oxohexan-2-yl]azanium Depiction based on curated SMILES O + N H H H + N H H H N H H + N H H H + N H H H CH 3 O N N H O H Staphylococcus Biofilm Preclinical (in vitro) Konai MM, et al. 2015. ACS Infect Dis
[(2S)-6-azaniumyl-1-[3-[3-[[(2S)-2,6-bis(azaniumyl)hexanoyl]amino]propyl-tetradecanoylamino]propylamino]-1-oxohexan-2-yl]azanium Depiction based on curated SMILES + N H H H HN O H + N H H H + N H H H O H 3 C N HN O H + N H H H Staphylococcus Biofilm Preclinical (in vitro) Konai MM, et al. 2015. ACS Infect Dis
   


NOTE: for more interactive and statistic charts, please visit the JavaScript-rich interface of VFDB.



Page 1  ...  71  72  73  74  75  76  77  78  79  80  81  82  83  84  85  86  87  88  89  90  91 



Back to top
2004-2025 NIPB, CAMS&PUMC